Freshpet Q4 Sales Top $285.2M, EPS Beats by 64.7%, Guides FY26 EBITDA Below Forecast
Freshpet delivered Q4 CY2025 revenue of $285.2M, up 8.6% year-on-year, matching consensus, and GAAP EPS of $0.64 beat estimates by 64.7%. The company set FY26 EBITDA guidance at $210M midpoint below $226.3M analyst forecast, despite widening operating margin to 15.6% and returning to positive free cash flow.
1. Q4 CY2025 Financial Results
Freshpet reported Q4 CY2025 revenue of $285.2M, up 8.6% year-on-year, aligning with expectations. GAAP EPS came in at $0.64, exceeding the $0.39 consensus by 64.7%, while adjusted EBITDA reached $61.15M, beating estimates by $3.26M.
2. Profitability and Cash Flow
Operating margin widened to 15.6% from 7.4% a year earlier. Sales volumes grew 9.7% year-on-year, though below last year’s 20.7% surge, and free cash flow turned positive at $2.06M versus a negative $7.90M a year ago.
3. FY2026 Outlook and Market Impact
The company guided to $210M of EBITDA at the midpoint for FY2026, below the $226.3M analyst forecast. This cautious outlook may temper upside after a mixed performance, despite exceeding profitability targets in Q4.